Illiasul Ibad/X
Aug 24, 2025, 18:21
Illiasul Ibad: How Clinical Trials Revolutionized ANCA Vasculitis Treatment from Cyclophosphamide to Rituximab
Illiasul Ibad, Rheumatologist at Christian Medical College, Vellore, shared a post on X:
“How clinical trials revolutionized ANCA vasculitis maintenance – from cyclophosphamide to rituximab, this is the journey of evidence, one trial at a time.
Facts. Timelines. Game-changers.
A must-read for every physician, rheumatologist, nephrologist, pulmonologist, and ophthalmologist. This is how science shaped the standard of care.
Special thanks to George Deva Raja for the image design.”
Stay updated with Hemostasis Today.
-
Jan 14, 2026, 16:22Leo Nicolai and Rainer Kaiser Link Procoagulant Platelets and Thromboinflammation in CVD
-
Jan 14, 2026, 16:01Renato Simonetti Presents a Pilot Project on AI-assisted Duplex Sonography for ICH
-
Jan 14, 2026, 15:47An Unusual Case from Mohammed Ameen: Unexpected Clot Unmasking Antithrombin III Deficiency
-
Jan 14, 2026, 11:38Khokon Miah Akanda Shares A major 4-Guideline Comparison on BP Management in Stroke
-
Jan 14, 2026, 11:26Pablo Albasanz-García and Colleagues on Anticancer Treatment-Induced Arterial and Venous Thrombosis
-
Jan 14, 2026, 11:16ISTH 2026: Laurent Bertoletti To Serve as Vice Theme Leader for VTE
-
Jan 14, 2026, 11:08Leni von Bonsdorff Invites You to Hear and Learn The Latest News in The Plasma Field
-
Jan 14, 2026, 05:56Arun V J on The “Whole Blood” Nostalgia Trap
-
Jan 13, 2026, 16:38Caitlin Raymond: Understanding TAMOF as a TTP-Like Process